Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
使用源自钙网蛋白外显子 9 突变的肽进行治疗性癌症疫苗接种可在 CALR 突变型慢性骨髓增生性肿瘤患者中诱导强烈的细胞免疫反应
期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2021.637420
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, Uffe Klausen, Stine Emilie Weis-Banke, Daniel El Fassi, Claudia Schöllkopf, Mette Borg Clausen, Lise Mette Rahbek Gjerdrum, Marie Fredslund Breinholt, Julie Westerlin Kjeldsen, Morten Hansen, Steffen Koschmieder, Nicolas Chat
